Form 4 - Statement of changes in beneficial ownership of securities
May 06 2024 - 6:51PM
Edgar (US Regulatory)
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
1. Name and Address of Reporting Person*
C/O RYERSON HOLDING CORPORATION |
227 W. MONROE ST., 27TH FLOOR |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp
[ RYI ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
|
10% Owner |
X |
Officer (give title below) |
|
Other (specify below) |
|
President & CEO |
|
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/03/2024
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock (par value ($0.01 per share) |
05/03/2024 |
|
M |
|
2,500 |
A |
$16.5
|
601,978.4833 |
D |
|
Common Stock (par value ($0.01 per share) |
05/06/2024 |
|
M |
|
1,250 |
A |
$16.5
|
603,228.4833 |
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Employee Stock Options (right to buy) |
$16.5
|
05/03/2024 |
|
M |
|
2,500 |
|
|
03/31/2031 |
Common Stock |
2,500 |
$0
|
10,000 |
D |
|
Employee Stock Options (right to buy) |
$16.5
|
05/06/2024 |
|
M |
|
1,250 |
|
|
03/31/2031 |
Common Stock |
1,250 |
$0
|
8,750 |
D |
|
Explanation of Responses: |
Remarks: |
|
/s/ Camilla Rykke Merrick, attorney-in-fact |
05/06/2024 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 99.1
Explanation of Responses
On March 31, 2021, the reporting person was granted 12,500 stock options, 1,250 of which vested on March 31, 2022, 2,500 of which vested
on March 31, 2023, and 3,750 vested on March 31, 2024. The remaining 5,000 unvested stock options will vest on March 31, 2025; provided, however, that the remaining unvested stock options will only become exercisable in the event that the average
closing price of the Company’s common stock during any consecutive 45 trading days within such year is equal to or greater than the respective target price for each year as set forth in the grant agreement, such target price equal to a 10%
cumulative increase each year relative to the average closing price of the Company’s common stock during the five trading days immediately preceding the date of grant. Any options that do not vest on a specified vesting date will remain eligible to
vest on the fifth anniversary of the grant date, if the average closing price of the Company’s common stock during any consecutive 45 trading days within such year is equal to or greater than the target price for such year, subject to the reporting
person’s continued employment with the Company through such date.
Exhibit 99.1
Explanation of Responses
On March 31, 2021, the reporting person was granted 12,500 stock options, 1,250 of which vested on March 31, 2022, 2,500 of which vested
on March 31, 2023, and 3,750 vested on March 31, 2024. The remaining 5,000 unvested stock options will vest on March 31, 2025; provided, however, that the remaining unvested stock options will only become exercisable in the event that the average
closing price of the Company’s common stock during any consecutive 45 trading days within such year is equal to or greater than the respective target price for each year as set forth in the grant agreement, such target price equal to a 10%
cumulative increase each year relative to the average closing price of the Company’s common stock during the five trading days immediately preceding the date of grant. Any options that do not vest on a specified vesting date will remain eligible to
vest on the fifth anniversary of the grant date, if the average closing price of the Company’s common stock during any consecutive 45 trading days within such year is equal to or greater than the target price for such year, subject to the reporting
person’s continued employment with the Company through such date.
Ryerson (NYSE:RYI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Ryerson (NYSE:RYI)
Historical Stock Chart
From Dec 2023 to Dec 2024